MEGAKARYOCYTE DIFFERENTIATION
巨核细胞分化
基本信息
- 批准号:2228408
- 负责人:
- 金额:$ 20.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-02-01 至 1998-01-31
- 项目状态:已结题
- 来源:
- 关键词:DNA footprinting RNase protection assay antisense nucleic acid cell differentiation gene expression genetic library genetic promoter element genetic regulation hematopoiesis megakaryocytes messenger RNA model northern blottings oligonucleotides polymerase chain reaction protooncogene tissue /cell culture transcription factor transfection
项目摘要
The long term objective of this research program is to significantly
enhance our understanding of megakaryopoeisis at the molecular level.
Three specific aims are proposed. The first is to document the role of
the c-ski proto-oncogene in megakaryopoeisis. Preliminary studies in
several human hematopoietic tumor cell lines showed that expression of
the c-ski proto-oncogene is specifically induced during in vitro
megakaryocyte differentiation but not during erythroid or myeloid
differentiation. The importance of ski expression in mediating
megakaryocyte differentiation will be tested by inhibiting its activity
in various hematopoietic cell lines through use of antisense
oligonucleotides, antisense RNA, ribozymes, and a dominant-negative
mutant of ski. Additionally, overexpression of ski in the same cell
lines will be examined to determine if ski expression, by itself, is
sufficient to induce the initial stages of megakaryocytic
differentiation. The ski protein appears to be a transcription factor
that binds specific responsive elements in DNA, and these sequences
have been located in the promoter regions of four
platelet/megakaryocytic specific genes, as well as in the upstream
region of the gene encoding the erythroid/megakaryocytic transcription
factor GATAI. Therefore, the role of ski-responsive elements in these
cell lines will also be examined, through the use of appropriate
reporter constructs. The second specific aim is to identify, in a model
cell line, CHRF-288-11, mRNAs whose expression changes during
megakaryocyte differentiation. These will be identified using two
recently developed PCR-based cDNA cloning techniques; differential
display, and a gene expression screen. Once obtained, these cDNAs will
be used for the experiments described in the third specific aim, which
is to determine if their expression is necessary and/or sufficient for
differentiation to occur. These experiments will employ overexpression
and inhibition of expression techniques similar to the ones outlined
in the first specific aim, in which the role of the c-ski protooncogene
was assessed. In this manner genes important in regulating
megakaryopoeisis will be identified allowing their mechanism(s) of
action to be determined. With this information in hand, it may become
feasible to design agents to artificially manipulate the expression of
these genes, which has important implications both for treating
diseases in which platelet production is impaired, and for engraftment
of megakaryocytes after bone marrow transplantation.
这项研究计划的长期目标是显著地
在分子水平上提高我们对巨核细胞生成的理解。
提出了三个具体目标。第一个是记录
巨核细胞生成中的c-ski原癌基因。中国的初步研究
几种人类造血肿瘤细胞系显示其表达
C-ski原癌基因在体外被特异性地诱导。
巨核细胞分化,但红系或髓系不分化
差异化。SKI表达在调解中的重要性
将通过抑制巨核细胞的活性来测试其分化
通过使用反义基因在不同的造血细胞系中
寡核苷酸、反义RNA、核酶和显性负性
滑雪的变种人。此外,SKI在同一细胞中过表达
将检查各行以确定ski表达式本身是否
足以诱导巨核细胞的初始阶段
差异化。SKI蛋白似乎是一种转录因子
它结合了DNA中特定的反应元件,这些序列
已经定位在四个启动子区域
血小板/巨核细胞特异性基因及其上游
编码红系/巨核细胞转录的基因区域
加泰因素。因此,滑雪反应元件在这些
细胞系也将通过使用适当的
记者构建。第二个具体目标是在模型中识别
CHRF-288-11细胞株,其表达在
巨核细胞分化。这些将使用两个
最近发展起来的基于聚合酶链式反应的cdna克隆技术;差异
显示,以及基因表达屏幕。一旦获得,这些DNA将
用于第三个具体目标中描述的实验,即
就是确定它们的表达对于
分化才会发生。这些实验将使用过度表达
和抑制表达技术,类似于概述的那些
在第一个特定目标中,c-ski原癌基因的作用
进行了评估。在这种情况下,重要的基因调控
巨核细胞生成将被确定为允许他们的机制(S)
行动待定。有了这些信息,它可能会成为
可行的设计代理人来人工操纵的表达
这些基因,这对治疗
血小板生成受损的疾病,并用于植入
骨髓移植后巨核细胞的数量。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL A LIEBERMAN其他文献
MICHAEL A LIEBERMAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL A LIEBERMAN', 18)}}的其他基金
相似海外基金
NOVEL RNASE PROTECTION ASSAY FOR CYTOKINE MRNAS
细胞因子 MRNAS 的新型 RNA 酶保护测定
- 批准号:
6317727 - 财政年份:2000
- 资助金额:
$ 20.74万 - 项目类别:














{{item.name}}会员




